Brief: Genscript Biotech Expects FY2025 Adjusted Net Profit Of US$207.3 Million-US$241.9 Million
March 10 (Reuters) - Genscript Biotech Corp 1548.HK: ADJUSTED NET PROFIT FOR FY2025 EXPECTED AT US$207.3 MILLION-US$241.9 MILLION LOSS FOR FY2025 EXPECTED AT US$505.8 MILLION-US$585.6 MILLION Further company coverage: 1548.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale